TEMLAGDI Trademark

Trademark Overview

On Thursday, June 22, 2017, a trademark application was filed for TEMLAGDI with the United States Patent and Trademark Office. The USPTO has given the TEMLAGDI trademark a serial number of 87501338. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, January 25, 2021. This trademark is owned by Bristol-Myers Squibb Company. The TEMLAGDI trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants and pharmaceutical antibodies
temlagdi

General Information

Serial Number87501338
Word MarkTEMLAGDI
Filing DateThursday, June 22, 2017
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, January 25, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 24, 2018

Trademark Statements

Goods and ServicesPharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants and pharmaceutical antibodies

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, June 29, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBristol-Myers Squibb Company
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10016
Party NameBristol-Myers Squibb Company
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10154

Trademark Events

Event DateEvent Description
Monday, January 25, 2021ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, January 25, 2021ABANDONMENT - NO USE STATEMENT FILED
Thursday, September 10, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 9, 2020EXTENSION 4 GRANTED
Friday, June 19, 2020EXTENSION 4 FILED
Tuesday, September 8, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, July 21, 2020NOTICE OF REVIVAL - E-MAILED
Monday, July 20, 2020EXTENSION RECEIVED WITH TEAS PETITION
Monday, July 20, 2020PETITION TO REVIVE-GRANTED
Monday, July 20, 2020TEAS PETITION TO REVIVE RECEIVED
Monday, July 20, 2020ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, July 20, 2020ABANDONMENT - NO USE STATEMENT FILED
Saturday, December 21, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, December 19, 2019EXTENSION 3 GRANTED
Thursday, December 19, 2019EXTENSION 3 FILED
Thursday, December 19, 2019TEAS EXTENSION RECEIVED
Friday, June 21, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 19, 2019EXTENSION 2 GRANTED
Wednesday, June 19, 2019EXTENSION 2 FILED
Wednesday, June 19, 2019TEAS EXTENSION RECEIVED
Friday, December 21, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, December 19, 2018EXTENSION 1 GRANTED
Wednesday, December 19, 2018EXTENSION 1 FILED
Wednesday, December 19, 2018TEAS EXTENSION RECEIVED
Monday, October 8, 2018APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, October 8, 2018TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, June 19, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 24, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 24, 2018PUBLISHED FOR OPPOSITION
Wednesday, April 4, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, March 22, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, March 20, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, March 19, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, March 19, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, September 19, 2017NOTIFICATION OF PRIORITY ACTION E-MAILED
Tuesday, September 19, 2017PRIORITY ACTION E-MAILED
Tuesday, September 19, 2017PRIORITY ACTION WRITTEN
Monday, September 18, 2017ASSIGNED TO EXAMINER
Thursday, June 29, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, June 26, 2017NEW APPLICATION ENTERED IN TRAM

Related Keywords

temlagdi diseases pharmaceutical human anti preparations disorders organ solid auto immune